# Emergency surgery for fibroid expulsion complicated by pelvic organ prolapse: a case report

**Authors:** Hirofumi Kawahara, Riho Yumisashi, Yuka Fukunishi, Masaki Kamio

PMC · DOI: 10.1093/jscr/rjaf215 · Journal of Surgical Case Reports · 2025-04-14

## TL;DR

A 52-year-old woman with fibroid expulsion and pelvic organ prolapse required emergency surgery after severe bleeding during hormone therapy.

## Contribution

This case report highlights the rare co-occurrence of fibroid expulsion and pelvic organ prolapse, emphasizing the need for surgical innovation and caution with GnRH antagonist therapy.

## Key findings

- Emergency surgery was required due to severe vaginal bleeding during Relugolix treatment.
- Hysterectomy and colporrhaphy were performed to treat fibroid expulsion and complete uterine prolapse.
- The case underscores the risks of abnormal uterine bleeding during GnRH antagonist therapy.

## Abstract

Uterine fibroids are common benign gynecological tumors. Submucosal fibroids, which protrude into the uterine cavity, may sometimes extend through the cervical canal as pedunculated masses, causing abnormal uterine bleeding (AUB). However, co-occurrence of fibroid expulsion with pelvic organ prolapse (POP) is rare. We report the case of a 52-year-old multiparous woman who was referred to our hospital for the treatment of fibroid expulsion and complete uterine prolapse. Hysterectomy and colporrhaphy were deemed necessary to alleviate these symptoms. Preoperative anemia was managed using oral Relugolix, a gonadotropin-releasing hormone (GnRH) antagonist, to reduce uterine bleeding. On the 33rd day of treatment, the patient presented with severe uncontrollable vaginal bleeding, necessitating emergency surgery. Abdominal and vaginal surgical approaches have been used for total hysterectomy, colporrhaphy and perineoplasty. This case highlights the necessity of surgical innovation in treating coexisting fibroid expulsion and POP and the potential risk of AUB during GnRH antagonist therapy.

## Linked entities

- **Chemicals:** Relugolix (PubChem CID 10348973)
- **Diseases:** pelvic organ prolapse (MONDO:0000082)

## Full-text entities

- **Genes:** GNRH1 (gonadotropin releasing hormone 1) [NCBI Gene 2796] {aka GNRH, GRH, LHRH, LNRH}
- **Diseases:** uterine prolapse (MESH:D014596), Uterine fibroids (MESH:D007889), bleeding (MESH:D006470), POP (MESH:D056887), anemia (MESH:D000740), gynecological tumors (MESH:D005833), AUB (MESH:D014592)
- **Chemicals:** Relugolix (MESH:C561634)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC11994993/full.md

## Figures

1 figure with captions in the complete paper: https://tomesphere.com/paper/PMC11994993/full.md

## References

10 references — full list in the complete paper: https://tomesphere.com/paper/PMC11994993/full.md

---
Source: https://tomesphere.com/paper/PMC11994993